ライフサイエンスコーパス: did not differ significantly

1 entified correctly with a dose of 2 MBq/kgBW; Likert scores did not differ significantly.

2 in infections, and similar infection in household contacts, did not differ significantly.

3 ]) Acute Physiology and Chronic Health Evaluation IV scores did not differ significantly (82 [75-98] vs 76 [70-96]; P = .

4 Declines in the size of peripheral populations did not differ significantly among tundra, fen and forest hab

5 to PrEP, the efficacy of daily oral PrEP for HIV prevention did not differ significantly among women with abnormal versus

6 The HIV prevention efficacy of PrEP did not differ significantly among women with healthy microbi

7 tal bacteria and individual species counts in dental plaque did not differ significantly between baseline and 3 months in

8 -forming units per mL), the number of vaccine serotype UTIs did not differ significantly between groups (0.046 mean episo

9 ence 0.3%, 95% CI -0.8 to 1.5; p=0.566) and neonatal deaths did not differ significantly between groups (six [2.0%] vs th

10 Most importantly, while the twofold clustering did not differ significantly between groups, blocking D2Rs si

11 absolute difference, -0.6%; 95% CI, -1.8% to 0.6%; P = .51) did not differ significantly between groups.

12 n, and serious adverse events, as well as 28-day mortality, did not differ significantly between groups.

13 tes of complete remission and the composite renal end point did not differ significantly between groups.

14 ants with the 72 unfunded grants, the overall success rates did not differ significantly between male (33.3%) and female

15 The mean values of D, D*, and Fp did not differ significantly between metastatic and non-metas

16 Cortical thickness did not differ significantly between multiple sclerosis subje

17 Self-reported depression symptoms did not differ significantly between patients given CBT and t

18 In the IC2/3 population (n=234), overall survival did not differ significantly between patients in the atezoliz

19 Times of disease-free survival and overall survival did not differ significantly between patients with PDACs with

20 related to levels of intraluminal gas, but peak gas levels did not differ significantly between responders, nonresponder

21 Ten-year regional recurrence did not differ significantly between the 2 groups.

22 Mean daily energy intakes did not differ significantly between the 3 groups.

23 The primary endpoint did not differ significantly between the ASV and control grou

24 All-cause mortality did not differ significantly between the canakinumab and plac

25 The distribution of CGRP-positive nerves did not differ significantly between the distal esophageal mu

26 Overall survival at 4 years did not differ significantly between the transplantation grou

27 The rate of symptomatic intracranial hemorrhage did not differ significantly between the two groups (6% in th

28 T and creatine kinase, and the rates of bleeding and stroke did not differ significantly between the two groups.

29 er, medullary thyroid carcinoma, and serious adverse events did not differ significantly between the two groups.

30 f attempts, and the incidence of traumatic tap and backache did not differ significantly between the two needle groups.

31 Sleep quality improved in both groups and did not differ significantly between them.

32 Spontaneous activity and energy expenditure did not differ significantly between treated and untreated mi

33 Pancreas graft survival at 1 year did not differ significantly between volume categories: 86%,

34 l for gestational age, stillbirth, and congenital anomalies did not differ significantly between women who were taking AR

35 HIV infection and mortality did not differ significantly by duration of breastfeeding (3.

36 e slightly older (median age, 60 vs 57 years; P < .001) but did not differ significantly by sex (43.2% vs 43.1% men; P =

37 Noncardiac and any cardiac deaths did not differ significantly by treatment.

38 tramadol ER (7 [19.4%]), or buprenorphine (3 [9.7%]) groups did not differ significantly (chi2 = 2.5, P = .29).

39 Three-year RFS and OS rates did not differ significantly for autoSCT (n = 62) versus non-

40 Three-year RFS and OS did not differ significantly for patients in the R-CHOP or in

41 Both ratio differences did not differ significantly from 0 (DN-to-pons ratio: -0.001

42 Groups 1 and 2 did not differ significantly from each other, whereas group 3

43 The GM-NDI of patients with bipolar I disorder did not differ significantly from either schizophrenia patien

44 ts (22 [61.1%]); tramadol ER retention was intermediate and did not differ significantly from that of the other groups (2

45 patients with serrated polyposis (0.51; 95% CI, 0.01-2.82) did not differ significantly from the SIR for CRC in patients

46 ents with irregular Z line and patients with BE of >/= 1 cm did not differ significantly in age, race, or duration of fol

47 A majority were females and Caucasian and groups did not differ significantly in terms of gender, race, or age

48 The groups did not differ significantly on any measure of psychopatholog

49 f reducing sugars, ethanol, acetic acid, and amino nitrogen did not differ significantly (p<0.05) between co-inoculation

50 Patients with or without linear lesions did not differ significantly with respect to sex, age, and cu